<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Otc Cold Drug Market Reports]]></title>
    <link>http://www.reportlinker.com/report/search/isAdwords//isCountryAdwords//theme/otc_cold_drug</link>
    <description><![CDATA[Reportlinker.com Lastest Otc Cold Drug Market Reports]]></description>
    <pubDate>Sat, 18 May 2013 19:53:00 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[The Indian Drug and Medication Business Brief]]></title>
      <link>http://www.reportlinker.com/d013786377/The-Indian-Drug-and-Medication-Business-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013786377/The-Indian-Drug-and-Medication-Business-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Gain, etc. Gastrointestinals -18.3%    Cough, <strong>cold</strong>, allergy-17.5% 3.4 Ayurvedic medicines: <strong>otc</strong> proprietary analgesic-14.3% <Strong>drugs</strong> which are registered as 'ayurvedic  Dermat-13.0% Medicines ...]]></description>
      <pubDate>Tue, 31 May 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d013715493/Drug-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013715493/Drug-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... In cough-<strong>cold</strong> <strong>drug</strong> products  for use as an anticholinergic. Anticho- linergic <strong>drugs</strong> have been marketed <strong>otc</strong>  in cough-<strong>cold</strong> <strong>drug</strong> products to relieve  excessive secretions of the nose and  eyes, symptoms ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d013474765/Drug-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013474765/Drug-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... In cough-<strong>cold</strong> <strong>drug</strong> products  for use as an anticholinergic. Anticho- linergic <strong>drugs</strong> have been marketed <strong>otc</strong>  in cough-<strong>cold</strong> <strong>drug</strong> products to relieve  excessive secretions of the nose and  eyes, symptoms ...]]></description>
      <pubDate>Sat, 30 Apr 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Drug and Medication Business Analysis]]></title>
      <link>http://www.reportlinker.com/d013643619/U-S-Drug-and-Medication-Business-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013643619/U-S-Drug-and-Medication-Business-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Around the country. The dea has removed more than 1.5 Million  pounds, or 774 tons of medication from circulation since the first take-back event in 2010,  according to the associated press. Safe <strong>drug</strong> ...]]></description>
      <pubDate>Thu, 31 May 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Drug and Medication Business Brief]]></title>
      <link>http://www.reportlinker.com/d012848987/U-S-Drug-and-Medication-Business-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012848987/U-S-Drug-and-Medication-Business-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Conclusion    Always take a complete history when  advising on pediatric <strong>otc</strong>  medications    Stay informed about new products  and dosage recommendations    Know when to say no   ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication Business Analysis  in Canada and The United States]]></title>
      <link>http://www.reportlinker.com/d012713679/Drug-and-Medication-Business-Analysis-in-Canada-and-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012713679/Drug-and-Medication-Business-Analysis-in-Canada-and-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Bronchodilator human <strong>drugs</strong>  for oral inhalation as an essential use. Approved ndas for <strong>otc</strong> epinephrine  mdis are currently held by wyeth consumer healthcare (wyeth) and  armstrong pharmaceuticals, inc ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Acetaminophen : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d012664169/Acetaminophen-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012664169/Acetaminophen-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Dextromethorphan, especially by adolescents. An fda advisory  panel reviewed the <strong>otc</strong> status of this <strong>drug</strong>, concluding that further  study was needed before any restriction for <strong>otc</strong> use would be  adopted.     79 ...]]></description>
      <pubDate>Mon, 31 Oct 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Drug and Medication Business]]></title>
      <link>http://www.reportlinker.com/d012639025/U-S-Drug-and-Medication-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012639025/U-S-Drug-and-Medication-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Ingredients in this <strong>drug</strong> class.  The panel  recommended that ephedrine and epinephrine preparations be placed in category i (generally  recognized as safe and effective or grase) for <strong>otc</strong> bronchodilator use (41 ...]]></description>
      <pubDate>Fri, 31 Dec 2010 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Syringe Sector in The United States]]></title>
      <link>http://www.reportlinker.com/d013996696/Syringe-Sector-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013996696/Syringe-Sector-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Year    Pharmacy syringe sales can help to decrease  hiv risk among injection <strong>drug</strong> users (idus)      pharmacies and <strong>otc</strong> syringe-selling  pharmacies in la county, 2008  results: cluster analyses  young population ...]]></description>
      <pubDate>Wed, 31 Oct 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Sector Analysis in The United States]]></title>
      <link>http://www.reportlinker.com/d012338707/Drug-Sector-Analysis-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012338707/Drug-Sector-Analysis-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... The patient S previous (or other treating)  physician before prescribing controlled  (substances).   47.1 Percent said that patients commonly tried to  pressure them into prescribing a controlled <strong>drug</strong> ...]]></description>
      <pubDate>Mon, 28 Feb 2011 23:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
